European annals of allergy and clinical immunology · 2005
Serum levels of the soluble interleukin-2 receptor in vitiligo patients in UAE.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Galadari I
Аннотация
OBJECTIVE: To determine serum level of slL-2 receptor in patients with vitiligo in a population in Al Ain, UAE.
DESIGN: This is a prospective, descriptive, hospital based study.
SETTING: Al Ain Medical District, Al Ain Hospital, UAE.
SUBJECTS: Vitiligo patients seen at Al Ain hospital in 2003.
RESULTS: The study was based on 32 patients. The sample consisted 21 males and 11 females. 15 healthy individuals were selected as control group. Serum level of slL-2R were significantly higher in vitiligo patient (112 +/- 129.2) than in healthy control (61.1 +/- 44.3 Pmol/L) P < 0.0001. Patient with short duration of the disease shows higher the serum level slL-2R.
CONCLUSION: slL-2R showed significant difference between vitiligo patients and control.
DESIGN: This is a prospective, descriptive, hospital based study.
SETTING: Al Ain Medical District, Al Ain Hospital, UAE.
SUBJECTS: Vitiligo patients seen at Al Ain hospital in 2003.
RESULTS: The study was based on 32 patients. The sample consisted 21 males and 11 females. 15 healthy individuals were selected as control group. Serum level of slL-2R were significantly higher in vitiligo patient (112 +/- 129.2) than in healthy control (61.1 +/- 44.3 Pmol/L) P < 0.0001. Patient with short duration of the disease shows higher the serum level slL-2R.
CONCLUSION: slL-2R showed significant difference between vitiligo patients and control.